0 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14217457 2023-04-01 2024-03-31 14217457 2024-03-31 14217457 2023-03-31 14217457 2022-04-01 2023-03-31 14217457 2023-03-31 14217457 2022-03-31 14217457 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 14217457 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 14217457 bus:Director1 2023-04-01 2024-03-31 14217457 core:WithinOneYear 2024-03-31 14217457 core:WithinOneYear 2023-03-31 14217457 core:ShareCapital 2024-03-31 14217457 core:ShareCapital 2023-03-31 14217457 core:RetainedEarningsAccumulatedLosses 2024-03-31 14217457 core:RetainedEarningsAccumulatedLosses 2023-03-31 14217457 bus:OrdinaryShareClass1 core:ShareCapital 2024-03-31 14217457 bus:OrdinaryShareClass1 core:ShareCapital 2023-03-31 14217457 bus:OrdinaryShareClass2 core:ShareCapital 2024-03-31 14217457 bus:OrdinaryShareClass2 core:ShareCapital 2023-03-31 14217457 bus:SmallEntities 2023-04-01 2024-03-31 14217457 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 14217457 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 14217457 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 14217457 bus:FullAccounts 2023-04-01 2024-03-31
REGISTRAR
Company registration number: 14217457
Belmont Healthcare Group 1 Limited
Unaudited filleted financial statements
31 March 2024
Belmont Healthcare Group 1 Limited
Contents
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Belmont Healthcare Group 1 Limited
Statement of financial position
31 March 2024
2024 2023
Note £ £ £ £
Current assets
Debtors 4 1,050,833 867,247
_______ _______
1,050,833 867,247
Creditors: amounts falling due
within one year 5 ( 1,053,093) ( 868,048)
_______ _______
Net current liabilities ( 2,260) ( 801)
_______ _______
Total assets less current liabilities ( 2,260) ( 801)
_______ _______
Net liabilities ( 2,260) ( 801)
_______ _______
Capital and reserves
Called up share capital 6 200 200
Profit and loss account ( 2,460) ( 1,001)
_______ _______
Shareholders deficit ( 2,260) ( 801)
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 11 November 2024 , and are signed on behalf of the board by:
A. N. Hutchison
Director
Company registration number: 14217457
Belmont Healthcare Group 1 Limited
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1st Floor Highlands House, Highlands Road, Solihull, B90 4ND.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.The financial statements are prepared in sterling, which is the functional currency of the entity.The accounts are rounded to the nearest £1.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
Loan and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a financing transaction it is measured at present value.
4. Debtors
2024 2023
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 1,050,633 867,047
Other debtors 200 200
_______ _______
1,050,833 867,247
_______ _______
5. Creditors: amounts falling due within one year
2024 2023
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest 1,051,833 867,048
Other creditors 1,260 1,000
_______ _______
1,053,093 868,048
_______ _______
6. Called up share capital
Issued, called up and fully paid
2024 2023
No £ No £
Ordinary shares of £ 1.00 each 100 100 100 100
Ordinary 'A' shares of £ 1.00 each 100 100 100 100
_______ _______ _______ _______
200 200 200 200
_______ _______ _______ _______